CONTRACT AWARD - Radioactive-labeled tracer Synthesis

FedBizOpps |

Notice Type: CONTRACT AWARD Posted Date: 25-JUN-14 Office: Food and Drug Administration Location: OFFICE OF ACQUISITIONS AND GRANTS SERVICES Office Address: DEPARTMENT OF HEALTH AND HUMAN SERVICES, FOOD AND DRUG ADMINISTRATION, OFFICE OF ACQUISITIONS AND GRANTS SERVICES, 5630 FISHERS LANE, ROOM 2129 ROCKVILLE, MD 20857-0001 Classification Code: 68 - Chemicals & chemical products Subject: Radioactive-labeled tracer Synthesis Solicitation Number: none listed Award Number: HHSF223201400016C Award Date: 062514 Awardee: 3D IMAGING DRUG DESIGN AND DEVELOPMENT, 8060 COUNTS MASSIE, NORTH LITTLE ROCK, AR 72113-6657 Contact: AARON A. GLAZIER, PHONE 8705437577, EMAIL AARON.GLAZIER@FDA.HHS.GOV Internet Link: https://www.fbo.gov/spg/HHS/FDA/DCASC/Awards/HHSF223201400016C.html

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
XXAAC AEI Income & Growth Fund Units LP Int XXI n/a n/a n/a 0

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…